Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates

Gene Therapy

Volumn 5, Issue 5, 1998, Pages 665-670

  Zhou, S ^a   Murphy, J E ^a   Escobedo, J A ^a   Dwarki, V J ^a,b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NONE   (United States)

Author keywords

Erythropoietin; Gene therapy; Nonhuman primates; Recombinant adeno associated virus

Indexed keywords

ERYTHROPOIETIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BABOON; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HEMATOCRIT; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ANIMALIA; DNA VIRUSES; PAPIO; PAPIO HAMADRYAS; PRIMATES;

EID: 0031834034     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300648     Document Type: Article

References (32)

1. Roe TY, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108.
2. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
3. Yang Y et al. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus infected hepatocytes in vivo. Gene Therapy 1996; 3: 137-144.
4. Manthorpe M et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993; 4: 4988-4997.
5. Blacklow NR et al. Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 1968; 8: 368-378.
6. Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Therapy 1995; 2: 357-362.
7. Atchinson RW, Casto BC, Hammond WM. Adenovirus-associated defective virus particles. Science 1965; 149: 754-756.
8. Flotte TR, Afione SA, Zeitlin PL. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 1994; 11: 517-521.
9. Mclaughlin SK, Collis P, Hermonat PL, Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 1988; 62: 1963-1973.
10. Kessler PD et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082-14087.
11. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 1992; 89: 10892-10895.
12. Clark KR, Sferra TJ, Johnson PR. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum Gene Ther 1997; 8: 659-669.
13. Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med 1997; 3: 306-312.
14. Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 5804-5809.
15. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectors. J Virol 1996; 70: 8098-8108.
16. Murphy JE et al. Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of a recombinant adeno-associated virus encoding mouse leptin. Proc Natl Acad Sci USA 1997; 94: 13921-13926.
17. Eschbach JW. The promise and the facts. Kidney Int 1994; 45: 70-76.
18. Koury ST, Bondurant MC, Koury MJ. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988; 71: 524-527.
19. Goldberg MA et al. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. New Engl J Med 1990; 323: 366-372.
20. Lin FK et al. Monkey erythropoietin gene: cloning, expression and comparison with the human erythropoietin gene. Gene 1986; 44: 201-209.
21. Schwartz TH et al. Thromboembolic complications of polycythemia: polycythemia vera versus smoker's polycythemia. J Vasc Surg 1993; 17: 518-522.
22. Barr D et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo. Gene Therapy 1995; 2: 151-155.
23. Kay MA et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus mediated gene transfer into mouse liver. Proc Natl Acad Sci USA 1997; 94: 4686-4691.
24. Sparer TE et al. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J Virol 1997; 71: 2277-2284.
25. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med 1996; 2: 545-550.
26. Deiss A. Destruction of erythrocytes. In: Lee GR et al (eds). Clinical Hematology. Lea and Febiger: Philadelphia, 1993, pp 195-222.
27. Svensson EC et al. Long-term erythropoietin expression in rodents and nonhuman primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997; 8: 1797-1806.
28. Manning WC et al. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J Virol 1997; 71: 7960-7962.
29. Zhou SZ et al. Adeno-associated virus 2 mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 1994; 179: 1867-1875.
30. Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 1996; 24: 596-601.
31. Srivastava A et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990; 76:1997-2000.
32. Jackson RJ, Fujihashi K, Kiyono H, McGhee JR. Luminometry: a novel bioluminescent immunoassay enhances the quantitation of mucosal and systemic antibody responses. J Immunol Meth 1996; 190: 189-197.